ARCA Biopharma News

About 67% of ARCA Biopharma's investor base is looking to short. The analysis of current outlook of investing in ARCA Biopharma suggests that many traders are alarmed regarding ARCA Biopharma's prospects. ARCA Biopharma's investing sentiment overview a quick insight into current market opportunities from investing in ARCA Biopharma. Many technical investors use ARCA Biopharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
over three months ago at news.google.com         
Why Are Hedge Funds Shorting ARCA Biopharma, Inc. - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Shareholder Alert Ademi LLP investigates Disclosure Issues involving ARCA biopharma, Inc.s Transacti...
Google News at Macroaxis
over six months ago at news.google.com         
ABIO Stock Earnings ARCA biopharma Reported Results for Q1 2024 - MSN
Google News at Macroaxis
over six months ago at news.google.com         
ARCA biopharma Earns Sell Rating from Analysts at StockNews.com - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
abrdn plc Takes 55000 Position in ARCA biopharma, Inc. - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
ARCA biopharma Research Coverage Started at StockNews.com - MarketBeat
Google News at Macroaxis
over six months ago at investorplace.com         
ABIO Stock Earnings ARCA biopharma Reported Results for Q1 2024
sbwire news
over six months ago at investorplace.com         
Disposition of 161 shares by Brian Selby of ARCA Biopharma at 2.56 subject to Rule 16b-3
sbwire news
over six months ago at finance.yahoo.com         
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
Yahoo News
over six months ago at benzinga.com         
Kuehn Law Encourages WIRE, ABIO, MODN, and SWAV Investors to Contact Law Firm
benzinga news
over six months ago at benzinga.com         
Acquisition by Robert Conway of 12000 shares of ARCA Biopharma at 4.31 subject to Rule 16b-3
benzinga news
over six months ago at news.google.com         
ARCA biopharma, Inc. Short Interest Up 6.6 percent in March - Defense World
Google News at Macroaxis
over six months ago at benzinga.com         
SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates SWAV, AIRC, ABIO, MODN
benzinga news
over six months ago at benzinga.com         
SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates SWAV, AIRC, MODN, ABIO
benzinga news
over six months ago at seekingalpha.com         
ARCA Biopharma stock drops on CEO departure
seekingalpha News
Far too much social signal, news, headlines, and media speculation about ARCA Biopharma that are available to investors today. That information is available publicly through ARCA media outlets and privately through word of mouth or via ARCA internal channels. However, regardless of the origin, that massive amount of ARCA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ARCA Biopharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ARCA Biopharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ARCA Biopharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ARCA Biopharma alpha.

ARCA Biopharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Janus Henderson Group Plc of 166042 shares of ARCA Biopharma at 3.5507 subject to Rule 16b-3
07/03/2024
2
Acquisition by Janus Henderson Group Plc of 16917 shares of ARCA Biopharma at 3.43 subject to Rule 16b-3
07/09/2024
3
Janus Henderson buys 1.43 million worth of ARCA Biopharma shares - Investing.com
07/12/2024
4
ARCA biopharma Upgraded to Sell by StockNews.com - Defense World
07/17/2024
5
ARCA biopharma GAAP EPS of -0.18
08/01/2024
6
Acquisition by Janus Henderson Group Plc of 5390 shares of ARCA Biopharma at 2.93 subject to Rule 16b-3
08/16/2024
7
Were Not Very Worried About ARCA biopharmas Cash Burn Rate
08/20/2024
8
ARCA biopharma declares 1.59 special dividend
08/26/2024
 
ARCA Biopharma dividend paid on 28th of August 2024
08/28/2024
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Consideration for investing in ARCA Stock

If you are still planning to invest in ARCA Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ARCA Biopharma's history and understand the potential risks before investing.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Content Syndication
Quickly integrate customizable finance content to your own investment portal